Back to search

National and Kapodistrian University of Athens

Βελτίωση της ποιότητας διαχείρισης των παραγόντων κινδύνου για αθηροσκλήρωση

Abstract

dc:description

Purpose of this study is to improve the quality of health care, concerning management of patients with risk factors of arteriosclerosis at a public health care in Greece.PATIENTS AND METHODSIn this study we measured the clinical indices of arteriosclerosis in two surgeries at the public primary healthcare centre in Vari, Attica, Greece (P.P.H.C.V.) which introduced stepped care for their patients. It consisted of keeping detailed files for all the patients attached to them. From these indices, choice was made for the ones concerned with hypertension, diabetes and lipids management. After face validity 51 clinical indices were chosen. Data analysis was performed with statistical program SPSS.12.0RESULTS Globally 166 patients were watched, for which files were kept with stepped care, 103 in surgery 1 and 63 in surgery 2. Also an accidental sample of 100 patients from the 2000 patients of (P.P.H.C.V.) was studied with usual care. TableI.Clinical indices concerning investigation of risk factors.(1.smoking,2.diabetes,3.dislipidemia,4.hypertension,5.B.M.I,6family history of angina) In the 2 years of study for patients with steped care all clinical indicators (c. i) in the table I had filled out to 100%. For patients with usual care, c.i, 2, 3, 4 at 99%, c.i. 5 (2%) for 1 and 2 N.E. (No Elements).TB.II.1.Clinical indices concerning investigation for end organ damages. number and% of patients being investigated for target organs damage and had the following elements arising from the specific history and clinical examination and have done the following examinations. (1. E.C.G., 2. urine,test 3. blowing of carotid art, 4. coronary heart disease, 5. strokeI 6. patients with record prices of kreatini, 7. palpation to determine distal arteries lower limbs) Calculated the CHI-SQUARE TEST for indicators 1, 2, 3, 6 and 7 and was statistically significant. The c.i. 4 changed by 94% to 100% and the indicator 5 of 92.8% to 100%. C.l values for patients with usual care were 1 (2%), 2 (2%), 3 (0), 4 (98%), 5 (98%), 6 (N.E.) Table III.Clinical indices concerning interventions for reduction of cardiovascular risk factors. number and % of patients (1. interventions for reducing smoking (number and percentage of patients who have made a proposal to stop smoking seminar), 2. BMI < 25, 3. diabetes mellitus patients who receive antihypertensive treatment, 4. (without contraindications) who receive daily aspirin, 5. Interventions to reduce BMI (number and percentage of patients who have set themselves targets of body weight or fitness program),6. to whom does not measure LDL-cholesterol). The c.i. 1 has changed from 0% to 100%, the c.i. 2 from 10% to 10.8%, c.i. 3 from 100 to 100%, No 4 c.i (N.E.), C.I. 5, N.E., C.I., 6 from 33,1 to 52,7%. For patients with the usual care data did not exist for any of the clinical indicators.Table IV. Clinical indices concerning prevention of complications/promotion of self care.% of patients (1. to whom lipids were checked at least every 12 months,2 in which the microalbumine was measured in the last 12 months, 3. submitted in ophthalmoscopy (mydriasi) in the last 12 months, 4. submitted to registered check of their feet in the past 12 months, 5. submitted in all these interventions, 6. who count documented (recorded on the health card) on their own blood glucose t in the last 12 months7. to whom the HbA1c measured at least every 6 months, 8. subject to annual examination for LDL-cholesterol). The c.i.1, 3, 7, 8 have decreased, 4, 6 improvement from 0 to 72,7% of 36,1 at 100%. For c.i. 2 and 5 N.E.. For control group N.E.Table V.Clinical indices concerning achievement of target treatment for B.P & ΗΒΑ1C & LIPIDS.Table.V. 2. change in average prices at times 0, 1, 2 years .(Mean value (M.V.) HBA1C, 2. LDL, TG 3., 4. SBP, 5. D.B.P). M.V at . times 0, 1, 2 years was calculated. The average price difference was statistically significant for all values other than triglycerides. For patients with usual care couldn't export price, because no data were found.Table VI.Clinical indices concerning follow up of patients after 2 years.number and% of patients with at least one visit to review for measuring B.P over the past months.(1.<6 μήνες, 2.=>6mines). the corresponding values are 95.7% and 4,3%.</6>CONCLUSIONS.Measurements of clinical indicators for the management of CVDs at the 2 clinics of General Medicine/Pathology, such as those proposed by health professionals to the Administration, are valid and helped improve the quality management of CVDs at these surgeries. There was improvement at all c.i.of tables I, II, III and V with the exception of table IV in which reduction observed in most c.i.. The difference with the control group was significant. For further improvements needed to address the weaknesses of the system, as defined by the strategic analysis of P.P.H.C.V. Addressing threats to public health which are CVDs, there is an urgent need for the expeditious growth of quality improvement processes in primary care units, on the initiative of health authorities.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dandoulakis, Michail
  • Δανδουλάκης, Μιχαήλ

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27248

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dandoulakis, Michail; Δανδουλάκης, Μιχαήλ. Βελτίωση της ποιότητας διαχείρισης των παραγόντων κινδύνου για αθηροσκλήρωση. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27248